The medical devices sector is typified by frequent change and innovation, in response to problems and issues faced by the healthcare industry. As a result, the sector has seen the emergence of several start-up medtech companies offering disruptive, cutting-edge solutions. Most of these are private companies, where data such as revenue is frequently not disclosed. National estimates for Liofilchem sales in the US from 2016 to 2022, as well as year-on-year growth rates, can be viewed in GlobalData’s micro revenue report. Buy the report here.
Liofilchem is a medical equipment company that designs and manufactures devices for microbiological tests. The company provides systems for microbial identification and susceptibility testing, MIC test strips, antibiotic discs in cartridges, dehydrated culture media, selective supplements, ready-to-use culture media in various formats (petri dish, tube, bottle, and dip-slide), as well as solutions for chemical and microbial screening in food and bio-indicators for sterilization process control systems. Its products are utilized in clinical and industrial microbiology laboratories worldwide. Liofilchem is headquartered in Roseto degli Abruzzi, Abruzzo, the US.
The key metrics of Liofilchem related to marketed and pipeline products, ongoing clinical trials, active jobs and publications from 2022 are shown below:
As Liofilchem is a privately held company, it is not required to disclose its financial information and there is no stock listed on an exchange. GlobalData has access to a proprietary data set containing invoice data from over 2,600 healthcare institutions in the US and is therefore able to use estimations of a company’s revenue and growth to value private companies such as Liofilchem.
For a detailed understanding of the performance of Liofilchem, buy the report here.